Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers

World News: . []

BOULDER Colo and MORRIS PLAINS, NJ June 03 2018 GLOBE NEWSWIRE -- NASDAQCLVSNASDAQIMMU today announced their intent to enter into a clinical collaboration to investigate the combination of Clovis Rubracarucaparib a poly AD P ribos...

More news and information about Immunomedics, Inc.

Published By:

Globe Newswire: 01:00 GMT Monday 4th June 2018

Published: .

Search for other references to "clovis" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us